Applying AI to adverse event case processing - Qinecsa

Applying AI to adverse event case processing

Qinecsa Chief Operating Officer, John Cogan, has been featured in Chimica Oggi Chemistry Today’s latest issue, where he discusses the impact of new therapy areas on the ever increasing pharmacovigilance workload, and how AI and automation are key to facilitating a smarter approach.

Read article

Recent Articles

The Productivity Crisis That Persists Even Now: What Will It Take to Free Up PV Professionals to Assess Safety, Rather Than Coordinate Data?

Embracing quantitative signal detection methods as a smaller MAH

Real-Time Safety Signals Drive Continuous PV Insight

From Complaint Handling to Active Surveillance

Continuous Safety Surveillance for Medical Devices

Are patient outcomes getting lost in safety data complexity?

PreviousHow smaller pharma teams are rethinking safety surveillance

NextDemocratising access to signal detection